Clinical Trial Update: Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy [EARLY_Phase 1]

View source ↗

Summary

This is a pilot early-phase imaging trial evaluating the HER2-targeted PET tracer [68Ga]Ga-ABY-025 in patients undergoing HER2-targeted therapy across several H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Squamous Cell Carcinoma
• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• [68Ga]Ga-ABY-025 (ABY-025)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Locally Advanced Cancer, Metastatic Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING